Search results
Where Will Iovance Biotherapeutics Stock Be in 5 Years?
Motley Fool via Yahoo Finance· 5 hours agoThe company announced a stock offering earlier this year, and it's likely that more offerings will...
Best biotech stocks to buy and hold in 2024: VKTX, SANA, RXRX
Invezz· 7 days agoBiotech stocks are having a relatively strong year as investors focus on the growing M&A in the...
Why Biogen Stock Leaped Nearly 5% Higher Today
Motley Fool via Yahoo Finance· 4 days agoThe 10 stocks that made the...2005... if you invested $1,000 at the time of our recommendation, you’d have $505,010!* Stock Advisor provides investors...
Biotech Stock Roundup: BIIB, BMY's Q1 Earnings, INCY's Acquisition & Updates from VRTX
Zacks via Yahoo Finance· 3 days agoYou can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Performance The...
Down -7.21% in 4 Weeks, Here's Why Krystal Biotech (KRYS) Looks Ripe for a Turnaround
Zacks· 6 days agoThe heavy selling pressure might have exhausted for Krystal Biotech (KRYS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement ...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 3 days agoAnalysts don't currently have any sales projections for future years, however. Today, Gyre stock has...
Vertex Pharmaceuticals Just Made 2 Big Moves. Is the Stock a Buy?
Motley Fool via Yahoo Finance· 6 days agoIt's time for a look at valuation. Vertex shares today trade for about 23 times forward earnings...
This Small-Cap Stock Is Up 140% This Year and Here's Why It Can Go Even Higher
Motley Fool via Yahoo Finance· 4 days agoMNMD Shares Outstanding data by YCharts. Should you buy Mind Medicine stock today? Mind Medicine is...
Why Amgen (AMGN) Outpaced the Stock Market Today
Zacks· 7 days agoFree Report) closed the latest trading day at $271.48, indicating a +0.95% change from the previous session's end. The stock outperformed the S&P 500, which registered a daily ...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 3 days agoPluvicto "paved the way," says David Song, of Tema ETFs. Tema owns the biotech stock, Fusion, and...
